The digital diabetes management market consists of sales of digital diabetes management devices and related services. Digital diabetes management includes devices, apps, and software that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patient’s blood glucose levels and controlling their conditions.
The global digital diabetes management market is expected to decline from $6.09 billion in 2019 to $6.03 billion in 2020 at a compound annual growth rate (CAGR) of -1.02%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $12.13 billion in 2023 at a CAGR of 26.27%.
